Anwaar Saeed, Michael J. Overman, Jason Timothy Henry, Alexander I. Spira, Naomi Fei, Nicholas C. DeVito, Nataliya V. Uboha, Dani Ran Castillo, Grace H. McGregor, Hui Zou, Ming Wang, Satya Das, Rita Laeufle, Harshabad Singh. "Phase 1/2 study of spevatamig (PT886) in combination with gemcitabine plus nab-paclitaxel (GnP) in frontline (1L) treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.709